Close this search box.

Clinical Trial: SWOG S1501

SWOG S1501

Status: Temporarily Closed

Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III

Eligible for screening study DCP 001

S1501 is temporarily closed to accrual, effective February 1, 2024 at 12pm Pacific Time.

S1501,  Arm 3 is permanently closed to accrual, effective July 29, 2021, at 11:59pm Pacific Time.